mirtazapine has been researched along with Dysembryoma in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, W | 1 |
| Yang, H | 1 |
| Piao, Y | 1 |
| Quan, M | 1 |
| Guo, D | 1 |
1 other study available for mirtazapine and Dysembryoma
| Article | Year |
|---|---|
Progressive multifocal leukoencephalopathy in a patient with mediastinal teratoma: a case report.
Topics: Aged; Brain; Female; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Mirtazapine; Ter | 2022 |